603811 诚意药业
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)9.49014.72316.36814.28815.580
总资产报酬率 ROA (%)7.86611.37511.0859.02010.625
投入资产回报率 ROIC (%)9.04813.16212.65110.17511.970

边际利润分析
销售毛利率 (%)71.20269.79969.53464.17768.424
营业利润率 (%)24.31927.64830.96525.89425.105
息税前利润/营业总收入 (%)24.27428.04931.67026.88725.534
净利润/营业总收入 (%)22.48124.30828.10724.12824.609

收益指标分析
经营活动净收益/利润总额(%)90.59877.86853.53968.55173.783
价值变动净收益/利润总额(%)10.12914.78419.82233.40026.327
营业外收支净额/利润总额(%)-0.518-0.339-1.4080.088-0.359

偿债能力分析
流动比率 (X)2.0791.4851.3501.5101.693
速动比率 (X)1.4781.0480.8981.1691.263
资产负债率 (%)15.47417.89026.80636.78036.540
带息债务/全部投入资本 (%)3.3701.73114.78825.75427.342
股东权益/带息债务 (%)2,810.7685,547.693561.756279.585257.363
股东权益/负债合计 (%)543.119456.559271.972171.272173.186
利息保障倍数 (X)299.24356.82627.91927.71849.226

营运能力分析
应收账款周转天数 (天)9.68512.29527.63636.46837.166
存货周转天数 (天)189.409182.091205.624170.442198.476